Implant-to-Market Initiatives to Accelerate the Translation of Research into Market-Ready Surgical Implantable Medical Devices by Strengthening Regulatory Science and Improved Regulatory Competencies Among Researchers
- Coordinator
- Institut National Polytechnique De Toulouse, France
- Runs
- 1 March 2027 to 28 February 2031
- Status
- Running
- EU funding
- €4.6m
- Total cost
- —
- Partners
- 20 organisations in 8 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101311759
What the project is doing
In the project's own words, from its summary on CORDIS.
Implant-to-Market will be a Doctoral Network (combining training and research) composed of 15 academic partners and 5 industrial partners (large companies and SMEs), focused on accelerating the translation of research into market-ready surgical implantable medical devices. Despite major scientific advances, the medical device sector, particularly implantable devices for surgery, still faces slow innovation transfer due to fragmented regulatory knowledge, limited cross-talk between scientists and regulatory experts, and shortages of skilled personnel.
Training is therefore essential to reinforce innovation capacity and global competitiveness. A European doctoral network integrating training and research is the most relevant instrument to address these challenges. The training programme developed in this project will be sustained beyond the project, and the qualifications of doctoral candidates and early-career researchers will be established by the consortium using shared methodologies.
The research methodology will rely on multidisciplinary and cross-sectoral collaborations involving universities, hospitals and industry. The work packages will address key needs: (i) integrating scientific data into regulatory processes and improving regulatory understanding among researchers; (ii) assessing safety and performance of implantable medical devices; (iii) reducing animal testing through alternative methods; (iv) developing multi-personalized and advanced medical devices; and (v) implementing sustainable-by-design strategies.
Expected outcomes include improved regulatory-science practices, enhanced qualification pathways, accelerated translation of innovations, and stronger interaction between research, clinics, regulation and industry. implant-to-market will help bridge the gap between scientific discovery and clinical adoption worldwide.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Institut National Polytechnique De Toulouse | Toulouse Cedex 4 | France | Coordinator |
| Cerhum | Liege | Belgium | Participant |
| Universite De Liege | Liege | Belgium | Participant |
| Dr. H. C. Robert Mathys Stiftung Fur Forschung, Dienstleistung, Technologietransfer Und Die Ausbildungsforderung in Der Medizinal - Und Werkstofftechnik | Bettlach | Switzerland | Participant |
| Eidgenoessische Technische Hochschule Zuerich | Zuerich | Switzerland | Associatedpartner |
| Eidgenossische Materialprufungs- Und Forschungsanstalt | Dubendorf | Switzerland | Participant |
| Lipal Biochemicals SA | Gundetswil | Switzerland | Associatedpartner |
| Universitaet Bern | Bern | Switzerland | Associatedpartner |
| Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV | Munchen | Germany | Participant |
| Universidad Politecnica De Madrid | Madrid | Spain | Participant |
| 3deus Dynamics SAS | Villeurbanne | France | Participant |
| Acm Pharma | Bellegarde | France | Participant |
| Centre Hospitalier Universitaire De Toulouse | Toulouse Cedex 3 | France | Associatedpartner |
| Fondation Hopital Saint Joseph | Paris | France | Associatedpartner |
| Sofradim Production Sasu | Trevoux | France | Participant |
| Universite De Toulouse | Toulouse | France | Associatedpartner |
| Politecnico Di Torino | Torino | Italy | Associatedpartner |
| Universita Degli Studi Di Padova | Padova | Italy | Participant |
| Stichting Radboud Universiteit | Nijmegen | Netherlands | Participant |
| Universidade Do Porto | Porto | Portugal | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI